| Gjertsen BT [In Process Citation] [Journal Article] Tidsskr Nor Laegeforen 2009 Sep 24; 129(18):1881-2. Full Citation | Find Related Articles |
| Kildahl-Andersen O, Holte J, Stalsberg H [50-year-old woman with elevated haemoglobin and iron deficiency.] [English Abstract, Journal Article] Tidsskr Nor Laegeforen 2009 Sep 24; 129(18):1878-81. Abstract | Full Citation |
| Sharman JE, Brown J, Holland DJ, et al. Influence of Altered Blood Rheology on Ventricular-Vascular Response to Exercise. [JOURNAL ARTICLE] Hypertension 2009 Aug 31. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Veneri D, Capuzzo E, de Matteis G, et al. Comparison of JAK2V617F mutation assessment employing different molecular diagnostic techniques. [Journal Article] Blood Transfus 2009 Jul; 7(3):204-9. Abstract | Full Citation |
| Hussein K, Bock O, Theophile K, et al. JAK2(V617F) allele burden discriminates essential thrombocythaemia from a subset of pre-fibrotic stage primary myelofibrosis. [JOURNAL ARTICLE] Exp Hematol 2009 Jul 16. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Wang X, Leblanc A, Gruenstein S, et al. Clonal Analyses Define the Relationships between Chromosomal Abnormalities and JAK2V617F in Patients with Ph-negative Myeloproliferative Neoplasms* [JOURNAL ARTICLE] Exp Hematol 2009 Jul 14. Abstract | Full Citation | Find Related Articles |
| Alvarez-Larrán A, Bellosillo B, Martínez-Avilés L, et al. Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients. [JOURNAL ARTICLE] Br J Haematol 2009 Jul 8. Abstract | Full Citation | Find Related Articles |
| Garber K JAK2 inhibitors: not the next imatinib but researchers see other possibilities. [News] J Natl Cancer Inst 2009 Jul 15; 101(14):980-2. Full Citation | Publisher Full Text | Find Related Articles |
| Carobbio A, Finazzi G, Antonioli E, et al. JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera. [JOURNAL ARTICLE] Exp Hematol 2009 Jun 23. Abstract | Full Citation | Find Related Articles |
| Mesa RA, Tefferi A Emerging drugs for the therapy of primary and post essential thrombocythemia, post polycythemia vera myelofibrosis. [JOURNAL ARTICLE] Expert Opin Emerg Drugs 2009 Jun 24. Abstract | Full Citation | Find Related Articles |
 |